Hartman Institute for Therapeutic Organ Regeneration

A forward chemical screen using zebrafish embryos with novel 2-substituted 2H-chromene derivatives.

TitleA forward chemical screen using zebrafish embryos with novel 2-substituted 2H-chromene derivatives.
Publication TypeJournal Article
Year of Publication2009
AuthorsTorregroza I, Evans T, Das BC
JournalChem Biol Drug Des
Volume73
Issue3
Pagination339-45
Date Published2009 Mar
ISSN1747-0285
KeywordsAnimals, Benzopyrans, Drug Evaluation, Preclinical, Embryonic Development, MAP Kinase Signaling System, Receptors, Transforming Growth Factor beta, Signal Transduction, Small Molecule Libraries, Zebrafish
Abstract

<p>We synthesized 2-substituted 2H-chromene derivatives from salicylaldehyde using potassium vinylic borates in the presence of secondary amines. Our goal was to generate novel compounds that might modulate transforming growth factor-beta signaling, based on limited rational design. Potassium vinyl trifluoroborates react with salicylaldehydes at 80 degrees C in the presence of a secondary amine and produce 2-substituted 2H-chromene derivatives with a 70-90% yield. A small library of these compounds, predicted to potentially interact with transforming growth factor-beta receptors, was screened for bioactivity in living zebrafish embryos. We found that the related compounds differentially affect development, and demonstrate one compound that produces severe body axis alterations in early embryogenesis and at lower doses affects specifically cardiovascular development. This compound modulates specifically a Smad-independent transforming growth factor-beta-regulated mitogen-activated protein kinase pathway, namely p-SAPK/JNK. These compounds, as suggested by our biological assays, may prove useful to manipulate developmental programs and develop therapeutic tools.</p>

DOI10.1111/j.1747-0285.2009.00782.x
Alternate JournalChem Biol Drug Des
PubMed ID19207470
PubMed Central IDPMC3133956
Grant ListHL56182 / HL / NHLBI NIH HHS / United States
R01 HL056182 / HL / NHLBI NIH HHS / United States
R37 HL056182 / HL / NHLBI NIH HHS / United States
R37 HL056182-14 / HL / NHLBI NIH HHS / United States
R01 HL064282 / HL / NHLBI NIH HHS / United States
HL64282 / HL / NHLBI NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065